Where is the manufacturer located?

The manufacturer, Perlong Medical Equipment Co., Ltd., is located in Nanjing, Jiangsu, China.

PT2000I Diathermy Machine High Frequency Electrosurgical Unit

Name: PT2000I Diathermy Machine High Frequency Electrosurgical Unit
Brand: Perlong Medical Equipment Co., Ltd.
SKU: 689298892

Jiangsu, ChinaPerlong Medical Equipment Co., Ltd.

US$1,100.00-1,300.00

1 Piece

Product profile

Customization

Available

Type

Electrosurgical Unit

Working Modes

Five Working Modes

Model NO.

PT2000I

Power Rating

1100va±10%

Transport Package

Export Standard Package

Specification

CE, ISO

Trademark

Seeuco

Origin

Nanjing, Jiangsu

Production Capacity

100units/Week

Key features

Five Working Modes: Supports Monopolar Cut, Blend, Coag1, Soft Coag, and Bipolar Coagulation.

Microcomputer Control: Ensures precise power control for all general surgical procedures.

Touch Control Panel: Features three-way power output with audible and visual indications.

Automatic Performance Check: Performs startup checks and Polar plate tests automatically.

REM and Power Peak System: Improves performance at lower power settings to minimize tissue damage.

Global Export Experience: Products exported to over 130 countries with WHO and UNICEF cooperation.

Fast Lead Time: Average lead time within 15 workdays for both peak and off-peak seasons.

Company profile

Perlong Medical Equipment Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2003-09-09Nearest Port: Shanghai, NingboAverage Response Time: ≤15hTerms of Payment: LC, T/T, Western Union, etc.International Commercial Terms(Incoterms): FOB, EXW, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, Others, FCA

AI-Powered supplier vetting

SummaryPerlong Medical Equipment Co., Ltd. is a China-based limited company in Nanjing, Jiangsu, engaged in medical-equipment trade and manufacturing. The supplier states that it has operated since 2003, possesses self-operated import and export rights, and derives 90% of sales from exports. Its product scope includes patient monitors, anesthesia, X-ray, laboratory, ECG, ultrasound, dental, ventilator, and biochemistry equipment. ISO 13485 and ISO 9001 management certifications are reported, along with 11–20 R&D engineers, 11–20 quality-control staff, and three production lines. The company claims exports to more than 140 countries and cooperation with WHO, UNDP, and UNICEF, but these claims are not independently substantiated in the provided data. The available trade records show transactions involving buyers in Uzbekistan and Tanzania, including patient-monitor shipments. Evidence is insufficient to assess financial credibility, customization capability, or the full extent of after-sales support.

Supplier typeThe supplier is identified as both a trading company and manufacturer/factory, operating as a limited company in Nanjing, China, with medical equipment as its commercial focus. Its stated product range and company profile support classification as a medical-equipment supplier with combined trading and manufacturing activities.

CertificationsThe supplier reports ISO 13485 and ISO 9001 management-system certifications. It also states that most products have obtained ISO certifications and that some have met CE and FDA requirements, although the specific certified products and certificate details are not provided.

Production capacityThe company is described as a manufacturer/factory as well as a trading company, with three production lines, 11–20 quality-control staff, and a factory location in Nanjing. Its stated manufacturing role and operating resources support production capability, although product-specific capacity and utilization are not provided.

Client casesThe supplier claims cooperation with WHO, UNDP, and UNICEF and exports to more than 140 countries. The trade records additionally identify ООО BAYMED INNOVATION in Uzbekistan and KAIRUKI HOSPITAL in Tanzania, including patient-monitor transactions; these records demonstrate named transaction cases but do not independently validate the broader international-client claims.